首先消灭Helicobacter pylori,或者治疗胃潰瘍疾病?
1Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
SAGE open medicine
|December 25, 2023
概括
治疗Helicobacter pylori感染和胃病的顺序不会影响治愈结果. 患者的性别和抗生素选择会影响H. pylori的根除,而类型会影响愈合.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 内部医学 内部医学
背景情况:
- 在全球范围内,Helicobacter pylori感染很普遍,有10-16%的感染者患有胃潰瘍疾病.
- 有限的研究存在于H. pylori根除和胃潰瘍疾病治疗的最佳序列.
研究的目的:
- 调查治疗顺序对H. pylori根除和胃潰瘍疾病对患者结局的影响.
- 确定影响H. pylori根除和胃潰瘍疾病治愈成功的因素.
主要方法:
- 对306名患有H. pylori感染和胃潰瘍疾病的成年患者进行了回顾性研究.
- 对初级治疗结果的分析,包括H. pylori的根除和胃潰瘍疾病的治愈.
- 评估患者的人口统计,类型和治疗方案,以了解它们对结果的影响.
主要成果:
- 治疗顺序没有显著影响H. pylori根除或胃潰瘍疾病愈合率.
- 与男性相比,女性患者的H. pylori根除率较低.
- 列沃素和澄胺的抗生素组合显示出最低的H. pylori根除疗效.
- 胃潰瘍比十二指腸潰瘍更有可能完全治愈.
结论:
- 根除H. pylori和治疗胃潰瘍疾病的序列对于主要结局并不重要.
- 患者的性别和抗生素选择是H. pylori根除成功的重要因素.
- 胃潰瘍疾病類型是潰瘍愈合結果的關鍵決定因素.
更多相关视频
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
411
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
411
Peptic Ulcer Disease IV: Management
95
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
95
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
435
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
435
Peptic Ulcer Disease I: Introduction
176
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
176
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
487
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
487
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
431
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
431


